Skip to main content

Table 2 Frequency of comorbidities, HD vintage, and etiology of ESKF according to dialysis centers(N = 224)

From: Frequency, types, and factors associated with complementary and alternative medicine use among patients on maintenance haemodialysis

Variable

N = 224

Yaounde

N = 105

Bamenda

N = 58

Buea

N = 61

 

Comorbidity

 Hypertension n(%)

188(83.9)

82(78.1)

52(89.7)

54(88.5)

 

 Diabetes mellitus n(%)

30(13.4)

14(13.3)

3(5.2)

13(21.3)

 

 HIV n(%)

20 (8.9)

7(6.7)

6(10.4)

7(11.5)

 

 Hepatitis C n(%)

16(7.1)

9(8.6)

2(3.4)

1(1.6)

 

 Hepatitis B n(%)

12 (5.4)

7(6.7)

7(12.1)

2(3.3)

 

 Physical disability n(%)

5 (2.2)

3(2.9)

0(0.0)

2(3.3)

 

Etiology of ESKF

 Hypertension n(%)

86(38.4)

40(38.1)

28(48.3)

18(29.5)

 

 CGN n(%)

65(29.0)

24(22.9)

17(29.3)

24(39.3)

 

 Diabetes n(%)

19(8.5)

11(10.5)

2(3.4)

6(9.8)

 

 HIV n(%)

14(6.3)

4(3.8)

3(5.2)

7(11.5)

 

 Unknown n(%)

11 (4.9)

7(6.9)

2(3.6)

2(3.1)

 

 CIN n(%)

9(4.0)

5(4.8)

4(6.5)

0(0.0)

 

 ADPKD n(%)

9(4.0)

4(3.9)

4(6.9)

1(1.6)

 

HD vintage in monthsa

a34.5 [17.3–64.4]

a38.6 [20.7–77.2]

a37.7 [19.1–77.5]

a28.9 [7.4–43.4]

 
  1. amedian [interquartile range], HIV Human immunodeficiency virus, ESKF End-stage kidney failure, CGN Chronic glomerulonephritis, CIN Chronic interstitial nephritis, ADPKD Autosomal dominant polycystic kidney disease, HD vintage Haemodialysis vintage or duration of haemodialysis therapy